PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'HIV Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.\', \'AIDS Monitoring Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, United States.\', \'Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD, United States.\', \'Division of Infectious Diseases and Tropical Medicine, Georgetown University Medical Center, Washington, DC, United States.\', \'Division of Hospital Medicine at MedStar Georgetown University Hospital, Washington, DC, United States.\', \'Section of Infectious Diseases, MedStar Washington Hospital Center, Washington, DC, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2022.815833
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35250994
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35250994>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35250994>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all